Non-invasive screening for neuroendocrine tumors—Biogenic amines as neoplasm biomarkers and the potential improvement of “gold standards”
详细信息 查看全文
- 作者：Natalia Miękusa ; Tomasz Bączekb ; tbaczek@gumed.edu.pl" class="auth_mail" title="E-mail the corresponding author
- 关键词：NET ; neuroendocrine tumors ; GI ; gastrointestinal track ; CgA ; chromogranin A ; BA ; biogenic amines ; 5-HT ; 5-hydroxytryptamine (serotonin) ; A ; adrenaline ; NA ; noradrenalin ; DA ; dopamine ; NBL ; neuroblastoma ; 5-HIAA ; 5-hydroxyindoleacetic acid ; CAT ; catecholamines ; IND ; indoleamines ; 5-HTP ; 5-hydroxytryptophan ; HVA ; homovanillic acid ; VMA ; vanillylmandelic acid ; DOPAC ; 3 ; 4-dihydroxyphenylacetic acid ; 3-MT ; 3-methoxytyramine ; L-DOPA ; levodopa ; RIA ; radioenzymatic assay ; GC ; gas chromatography ; HPLC&nd
- 刊名：Journal of Pharmaceutical and Biomedical Analysis
- 出版年：2016
- 出版时间：25 October 2016
- 年：2016
- 卷：130
- 期：Complete
- 页码：194-201
- 全文大小：420 K
文摘
- •
Neuroendocrine tumors management “gold standards” could be routinely modified.
- •
Determination of biogenic amines (catecholamines, indoleamines) in biological samples is still challenging task in clinical practice.
- •
Review on the recent status of biogenic amines analysis in terms of analytical method development is the subject of the interest.